awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48538147-52B7407D-468E-4DD8-87E7-85369834A48E
Q48538147-52B7407D-468E-4DD8-87E7-85369834A48E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48538147-52B7407D-468E-4DD8-87E7-85369834A48E
A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.
P2860
Q48538147-52B7407D-468E-4DD8-87E7-85369834A48E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48538147-52B7407D-468E-4DD8-87E7-85369834A48E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1862ea1fca74288b621735c7663bef9798f18950
P2860
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.